{"id":"https://openalex.org/W4404097635","doi":"https://doi.org/10.1183/13993003.congress-2024.pa4118","title":"Relation between treatable traits, treatment (Tx) choices and symptom control/exacerbation (exac) risk in moderate\u2013severe asthma","display_name":"Relation between treatable traits, treatment (Tx) choices and symptom control/exacerbation (exac) risk in moderate\u2013severe asthma","publication_year":2024,"publication_date":"2024-09-14","ids":{"openalex":"https://openalex.org/W4404097635","doi":"https://doi.org/10.1183/13993003.congress-2024.pa4118"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2024.pa4118","doi":"https://doi.org/10.1183/13993003.congress-2024.pa4118","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2024.pa4118","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rehabilitation and chronic care","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086530672","display_name":"Gabriel Garc\u00eda","orcid":"https://orcid.org/0000-0002-4268-4960","observed_orcids":["https://orcid.org/0000-0002-4268-4960"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel Garcia","raw_affiliation_strings":["1Respiratory Research Center, CEPIR, La Plata, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Respiratory Research Center, CEPIR, La Plata, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037297396","display_name":"Pierluigi Paggiaro","orcid":"https://orcid.org/0000-0002-1213-2989","observed_orcids":["https://orcid.org/0000-0002-1213-2989"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pierluigi Paggiaro","raw_affiliation_strings":["2University of Pisa, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001192345","display_name":"Nicol\u00e1s Roche","orcid":"https://orcid.org/0000-0002-3162-5033","observed_orcids":["https://orcid.org/0000-0002-3162-5033"]},"institutions":[{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241","https://openalex.org/I40434647","https://openalex.org/I4210124654","https://openalex.org/I48825208"]},{"id":"https://openalex.org/I4210092774","display_name":"H\u00f4pital Cochin","ror":"https://ror.org/00ph8tk69","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210092774","https://openalex.org/I4210097159","https://openalex.org/I4210124464"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Roche","raw_affiliation_strings":["3H\u00f4pital Cochin; Universit\u00e9 Paris Cit\u00e9, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3H\u00f4pital Cochin; Universit\u00e9 Paris Cit\u00e9, Paris, France","institution_ids":["https://openalex.org/I204730241","https://openalex.org/I4210092774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065134876","display_name":"Sean P. Oosterholt","orcid":"https://orcid.org/0000-0002-4346-0088","observed_orcids":["https://orcid.org/0000-0002-4346-0088"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sean Oosterholt","raw_affiliation_strings":["4GSK, Brentford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4GSK, Brentford, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062542381","display_name":"Janna K. Duong","orcid":"https://orcid.org/0000-0003-2347-7277","observed_orcids":["https://orcid.org/0000-0003-2347-7277"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janna Duong","raw_affiliation_strings":["5GSK, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5GSK, Sydney, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062449253","display_name":"Manish Verma","orcid":"https://orcid.org/0000-0003-2618-4277","observed_orcids":["https://orcid.org/0000-0003-2618-4277","https://orcid.org/0000-0002-8878-0069"]},"institutions":[{"id":"https://openalex.org/I4210099842","display_name":"GlaxoSmithKline (India)","ror":"https://ror.org/01tvt4d48","country_code":"IN","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210099842"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Manish Verma","raw_affiliation_strings":["6GSK, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6GSK, Mumbai, India","institution_ids":["https://openalex.org/I4210099842"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048620231","display_name":"Anurita Majumdar","orcid":"https://orcid.org/0000-0002-8047-9378","observed_orcids":["https://orcid.org/0000-0002-8047-9378"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anurita Majumdar","raw_affiliation_strings":["7GSK, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7GSK, Singapore, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059497342","display_name":"Maximilian W. Plank","orcid":"https://orcid.org/0000-0002-2111-1370","observed_orcids":["https://orcid.org/0000-0002-2111-1370"]},"institutions":[{"id":"https://openalex.org/I78757542","display_name":"University of Newcastle Australia","ror":"https://ror.org/00eae9z71","country_code":"AU","type":"education","lineage":["https://openalex.org/I78757542"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Maximilian Plank","raw_affiliation_strings":["8GSK, Munich, (Germany); University of Newcastle, Newcastle, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8GSK, Munich, (Germany); University of Newcastle, Newcastle, Australia","institution_ids":["https://openalex.org/I78757542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060615943","display_name":"Shalini Girotra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shalini Girotra","raw_affiliation_strings":["7GSK, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7GSK, Singapore, Singapore","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081960928","display_name":"Oscar E. Della Pasqua","orcid":"https://orcid.org/0000-0002-6211-1430","observed_orcids":["https://orcid.org/0000-0002-6211-1430"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Oscar Della Pasqua","raw_affiliation_strings":["9GSK, Brentford, (United Kingdom); University College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9GSK, Brentford, (United Kingdom); University College London, London, United Kingdom","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA4118","last_page":"PA4118"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12208","display_name":"Occupational exposure and asthma","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/moderate-to-severe-asthma","display_name":"moderate-to-severe asthma","score":0.9390000104904175},{"id":"https://openalex.org/keywords/asthma-exacerbation-risk","display_name":"asthma exacerbation risk","score":0.9120000004768372},{"id":"https://openalex.org/keywords/asthma-symptom-control","display_name":"asthma symptom control","score":0.7730000019073486},{"id":"https://openalex.org/keywords/fluticasone-furoate-vilanterol","display_name":"fluticasone furoate/vilanterol","score":0.902999997138977},{"id":"https://openalex.org/keywords/budesonide-formoterol","display_name":"budesonide/formoterol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fluticasone-propionate","display_name":"fluticasone propionate","score":0.8450000286102295},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.753000020980835},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.8109999895095825},{"id":"https://openalex.org/keywords/smoking","display_name":"smoking","score":0.8740000128746033},{"id":"https://openalex.org/keywords/lung-function","display_name":"lung function","score":0.828000009059906}],"concepts":[{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.6376370191574097},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.6051679849624634},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5359649658203125},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3598789572715759},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2914566397666931}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2024.pa4118","doi":"https://doi.org/10.1183/13993003.congress-2024.pa4118","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2024.pa4118","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rehabilitation and chronic care","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/2","display_name":"Zero hunger","score":0.44999998807907104}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1957770986"],"abstract_inverted_index":{"Introduction":[0],"Appropriate":[1],"individualisation":[2],"of":[3,10,19,127,168],"asthma":[4,189,197],"Tx":[5,13,128],"requires":[6],"identifying":[7],"relevant":[8],"determinants":[9],"control/risk":[11],"including":[12],"effect.":[14],"Aim":[15],"To":[16,65],"quantify":[17],"effects":[18],"baseline":[20,62,141],"characteristics/Tx":[21,63],"on":[22,52,78,170],"symptom":[23],"control":[24],"(Asthma":[25],"Control":[26],"Questionnaire":[27],"[ACQ-5])":[28],"and":[29,38,48,114,166,172,193],"exac":[30,124,131,153],"risk":[31,125,181],"reduction":[32],"in":[33,98,118,138,151],"moderate\u2013severe":[34],"asthma.":[35],"Methods":[36],"Exac":[37],"ACQ-5":[39,142,175],"were":[40,74,92],"simulated":[41],"for":[42],"1":[43,119],"year":[44],"(yr)":[45],"via":[46],"time-to-event":[47],"longitudinal":[49],"models":[50],"(based":[51],"data:":[53],"6763":[54],"patients":[55],"[pts],":[56],"9":[57],"studies).":[58],"Heat":[59],"maps":[60],"separated":[61],"effects.":[64],"mimic":[66],"clinical":[67],"practice,":[68],"data":[69],"from":[70],"a":[71],"16000":[72],"pt-cohort":[73],"modelled":[75],"to":[76,83,148],"initiate":[77],"fluticasone":[79,84],"propionate,":[80],"then":[81],"stepped-up":[82],"furoate/vilanterol":[85],"(FF/VI)":[86],"or":[87],"budesonide/formoterol":[88],"(BUD/FOR)":[89],"if":[90],"symptoms":[91],"not":[93],"well":[94],"controlled":[95],"(ACQ-5":[96],"\u22651.5)":[97],"0.25yr.":[99],"A":[100],"log-rank":[101],"test":[102],"analysed":[103],"cumulative":[104],"exac.":[105],"Results":[106],"ACQ-5,":[107],"body":[108],"mass":[109],"index":[110],"(BMI),":[111],"sex,":[112],"smoking":[113],"forced":[115],"expiratory":[116],"volume":[117],"second":[120],"%":[121],"predicted":[122],"affect":[123],"independently":[126],"(p<0.01).":[129,146],"Cumulative":[130],"frequency":[132],"after":[133],"1yr":[134],"was":[135],"~11%":[136],"lower":[137,152],"pts":[139,169],"with":[140],"\u22640.75":[143],"vs":[144,155,158],">1.5":[145],"Step-up":[147],"FF/VI":[149,171],"resulted":[150],"rate":[154],"BUD/FOR":[156,173],"(14.7%":[157],"23.9%;":[159],"p<0.01;":[160],"Fig":[161],"1).":[162],"At":[163],"1yr,":[164],"81.1%":[165],"75.7%":[167],"had":[174],"\u22641.5":[176],"(p<0.01),":[177],"respectively.":[178],"Conclusions":[179],"ACQ-5/exac":[180],"are":[182],"modulated":[183],"by":[184],"pt":[185],"characteristics":[186],"(BMI,":[187],"sex),":[188],"control,":[190],"lung":[191],"function":[192],"Tx,":[194],"highlighting":[195],"personalised":[196],"management":[198],"importance.":[199],"erj;64/suppl_68/PA4118/F1":[200],"F1":[201,202]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}